Provided by Tiger Trade Technology Pte. Ltd.

Halozyme Therapeutics

109.32
+1.601.49%
Volume:826.70K
Turnover:89.63M
Market Cap:12.41B
PE:32.32
High:109.33
Open:105.48
Low:105.48
Close:107.72
52wk High:109.66
52wk Low:61.23
Shares:113.50M
Float Shares:112.00M
Volume Ratio:0.70
T/O Rate:0.74%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.38
EPS(LYR):2.56
ROE:173.67%
ROA:25.49%
PB:86.44
PE(LYR):42.70

Loading ...

Nexalin Technology Advances Pivotal Clinical Trial of HALO™ Clarity Toward Q2 2026 Enrollment

GlobeNewswire
·
Apr 22

Halozyme price target raised to $96 from $94 at Morgan Stanley

TIPRANKS
·
Apr 21

Investment Focus on Tech Innovation and HALO Assets Becomes Clearer This Year

Deep News
·
Apr 20

HALO Trading: Fleeting Trend or Enduring Investment Strategy?

Deep News
·
Apr 18

Market Opportunities Remain Plentiful in Q2, Focus on Tech and HALO Assets

Deep News
·
Apr 16

HALO Asset Revaluation: Oil & Gas ETF ICBC (159017) Focuses on Full Industry Chain

Deep News
·
Apr 16

ALX Oncology names Jeff Knight chief development and operating officer

Reuters
·
Apr 13

KKR Says Uncertainty Is Creating Opportunities In Private Markets

Benzinga_recent_news
·
Apr 10

Long-Term Growth Prospects Emerge for 'HALO' Assets Amid AI Wave

Deep News
·
Apr 09

Neogen names Jennifer Evans Stacey chief legal, compliance officer, board secretary

Reuters
·
Apr 08

Hua An Fund: Banks and HALO Assets Show Resilience, Dividend Strength Stands Out

Deep News
·
Apr 08

Halozyme CEO Helen Torley disposes of common shares worth $633,384

Reuters
·
Apr 08

BRIEF-Halozyme Announces Global Collaboration And License Agreement With Vertex Pharmaceuticals For Hypercon™ Technology

Reuters
·
Apr 07

Halozyme signs exclusive Hypercon licensing deal with Vertex for up to three targets

Reuters
·
Apr 07

Halozyme Therapeutics Inc - Vertex Licenses Halozyme's Hypercon Technology for up to Three Drug Targets

THOMSON REUTERS
·
Apr 07

Halozyme Announces Global Collaboration and License Agreement With Vertex Pharmaceuticals for Hypercon™ Technology

THOMSON REUTERS
·
Apr 07

Zhongtai Securities: HALO Framework Reassesses Value of Scarce Assets, Foresees Commercial Revaluation of Publishing Firms

Stock News
·
Apr 03

Halozyme CEO Helen Torley disposes of USD 2.61 million common shares

Reuters
·
Apr 03

F1 Defies AI Disruption: Liberty Formula One (FWONK.US) Showcases "HALO Premium" Amid Market Turmoil

Stock News
·
Apr 02

Is Halozyme Therapeutics (HALO) Pricing Reflect Its Potential After Recent Share Price Pullback

Simply Wall St.
·
Mar 31